Salzman & Co’s HCA Healthcare HCA Stock Holding History

Salzman & Co’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,675	Closed	-$779K	–	4
2020 Q1	$779K	Hold	8,675	–	–	2.62%	8
2019 Q4	$1.28M	Buy	+8,675	New	+$1.16M	25.21%	2

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Salzman & Co's HCA Position: Q2 2020 in Review

Salzman & Co sold out of HCA Healthcare (HCA) in Q2 2020, closing a stake of 8,675 shares — an estimated $779K sold.

Salzman & Co first reported a position in HCA in Q4 2019 and held it in 2 quarters. The position peaked at $1.28M in Q4 2019. 685 funds tracked by Wall St. Rank hold HCA as of Q2 2020.

Salzman & Co reported no remaining HCA Healthcare position as of Q2 2020 after selling out during the quarter.
Salzman & Co sold 8,675 HCA Healthcare shares in Q2 2020, an estimated $779K.
Salzman & Co first reported a position in HCA Healthcare in Q4 2019 and held it in 2 quarters.
Salzman & Co's HCA Healthcare position peaked at $1.28M in Q4 2019.
685 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2020.

Based on Salzman & Co's 13F filing for Q2 2020.